Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
884.31B
Market cap884.31B
Price-Earnings ratio
40.08
Price-Earnings ratio40.08
Dividend yield
0.68%
Dividend yield0.68%
Average volume
2.70M
Average volume2.70M
High today
$929.00
High today$929.00
Low today
$911.89
Low today$911.89
Open price
$927.32
Open price$927.32
Volume
2.15M
Volume2.15M
52 Week high
$1,133.95
52 Week high$1,133.95
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

With a market cap of 884.31B, Eli Lilly(LLY) trades at $918.94. The stock has a price-to-earnings ratio of 40.08 and currently yields dividends of 67.7%.

During the trading session on 2026-04-23, Eli Lilly(LLY) shares reached a daily high of $929.00 and a low of $911.89. At a current price of $918.94, the stock is +0.8% higher than the low and still -1.1% under the high.

Trading volume for Eli Lilly(LLY) stock has reached 2.15M, versus its average volume of 2.7M.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.

LLY News

TipRanks 5h
Eli Lilly Expands Partnership with Hims & Hers

The stock of Hims & Hers Health (HIMS) was up as much as 7% on April 23 after the company announced that it has expanded its partnership with Eli Lilly (LLY)....

Barron's 6h
Hims Stock Falls as It Pivots From GLP-1 Compounding. Why the ‘Netflix’ Argument Is Failing.

Biotech and Pharma Hims Stock Falls as It Pivots From GLP-1 Compounding. Why the ‘Netflix’ Argument Is Failing. In this article LLY NVO SPX Eli Lilly is the mak...

Hims Stock Falls as It Pivots From GLP-1 Compounding. Why the ‘Netflix’ Argument Is Failing.
Simply Wall St 8h
Hims & Hers Health Is Up 19.4% After Expanding GLP-1 Access Via LillyDirect Integration

Earlier this week, Hims & Hers Health said clinicians on its platform can now prescribe Eli Lilly GLP-1 weight loss drugs, which will be filled through LillyDir...

Hims & Hers Health Is Up 19.4% After Expanding GLP-1 Access Via LillyDirect Integration

Analyst ratings

83%

of 35 ratings
Buy
82.9%
Hold
14.3%
Sell
2.9%

More LLY News

Sherwood News 11h
Hims rises after it says it now offers “full range” of FDA-approved GLP-1s

Hims & Hers rose in early trading after it announced that it now allows its providers to prescribe medications that are fulfilled by independent pharmacies, mea...

Hims rises after it says it now offers “full range” of FDA-approved GLP-1s
Investor's Business Daily 11h
Hims & Hers Jumps On Its New Eli Lilly-Tied Approach To Obesity

Obesity Drugs Covered In Medicare Change. Questions Remain For Lilly, Novo. 4/22/2026 CMS flipped its stance late Tuesday, saying it will cover the cost of obe...

Hims & Hers Jumps On Its New Eli Lilly-Tied Approach To Obesity
The Motley Fool 15h
Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins

Investors looking to capitalize on the rapidly growing weight-loss market face a difficult choice. Eli Lilly (LLY +2.04%) is the leader in the field, but some w...

Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins
The Motley Fool 1d
Is Eli Lilly Stock Actually ... Cheap? The Surprising Math Behind Its 2026 Valuation.

At first glance, Eli Lilly's (LLY +1.97%) current share price of $903 feels like a psychological barrier. Most investors fixate on the absolute dollars and assu...

Is Eli Lilly Stock Actually ... Cheap? The Surprising Math Behind Its 2026 Valuation.
TipRanks 1d
Bernstein Pounds the Table on Eli Lilly Stock Ahead of Q1 Earnings

Wall Street brokerage Bernstein is pounding the table on Eli Lilly (LLY) stock ahead of the pharmaceutical company’s first-quarter financial results on April 30...

TipRanks 2d
Eli Lilly price target raised to $1,183 from $1,163 at Guggenheim

Guggenheim raised the firm’s price target on Eli Lilly (LLY) to $1,183 from $1,163 and keeps a Buy rating on the shares. The firm is updating its model ahead of...

TipRanks 2d
Rigel: Core Growth Thesis Intact Despite Eli Lilly’s R552 Exit, With Commercial Portfolio and R289 Pipeline Driving Buy Rating

In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Rigel, with a price target of $57.00. Claim 30% Off TipRanks Unlock...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.